Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
FLT3-IN-17 is a dual inhibitor of FMS-related tyrosine kinase 3 (FLT3) expressing a D835Y mutation associated with quizartinib resistance and focal adhesion kinase (FAK; IC50s = <0.5 and 12 nM in cell-free assays).1 It inhibits the growth of HCT116 colorectal cancer cells, MDA-MB-231 breast cancer cells, and A375 human melanoma cells (GI50s = 0.25, 0.46, and 0.49 µM, respectively).
WARNING This product is not for human or veterinary use.
1. Identification of thieno[3,2-